lifestyle.forkstofeet.com

Author: Pelthos Therapeutics, Inc.

Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

April 14, 2026
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

March 31, 2026
Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026
Pelthos Therapeutics to Present at 38th Annual ROTH Conference

March 12, 2026
Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

March 9, 2026
Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 23, 2026